United States
Germany
Japan
United Kingdom
China
Kat8 (NM_026370) Mouse Tagged ORF Clone Lentiviral Particle
CAT＃: MR207314L4V
- LentiORF®
-
Lenti ORF particles, Kat8 (GFP-tagged) - Mouse MYST histone acetyltransferase 1 (Myst1), 200ul, >10^7 TU/mL
Mouse Protein / Lysate Request
Need custom lentivirus service?
Get a free quote
CNY 10,070.00
货期*
详询
规格
Product images
经常一起买 (2)
Specifications
| Product Data | |
| Product Name | Kat8 (NM_026370) Mouse Tagged ORF Clone Lentiviral Particle |
| Synonyms | 2010203C02Rik; 5830450F21Rik; D7Ertd629e; MOF; Myst1 |
| Vector | pLenti-C-mGFP-P2A-Puro |
| ACCN | NM_026370 |
| ORF Size | 1377 bp |
| Sequence Data |
The ORF insert of this clone is exactly the same as(MR207314).
|
| OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
| OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
| Reference Data | |
| RefSeq | NM_026370.1, NP_080646.1 |
| RefSeq Size | 1503 bp |
| RefSeq ORF | 1377 bp |
| Locus ID | 67773 |
| Gene Summary | Histone acetyltransferase which may be involved in transcriptional activation. May influence the function of ATM. As part of the MSL complex it is involved in acetylation of nucleosomal histone H4 producing specifically H4K16ac. As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues. That activity is less specific than the one of the MSL complex. Can also acetylate TP53/p53 at 'Lys-120'.[UniProtKB/Swiss-Prot Function] |
Documents
| Product Manuals |
| FAQs |
| SDS |
Resources
You may also need
Customer
Reviews
Loading...
